Month: November 2020

AstraZeneca’s COVID-19 vaccine is up to 90% effective, the company said Monday in a press release, making it the third pharmaceutical firm to report promising vaccine news, following Pfizer and Moderna. AstraZeneca, which partnered with University of Oxford researchers to develop its two-dose vaccine, reported efficacy from two different dosing regimens; one led to 62% … Read more

With three vaccine makers—Pfizer, Moderna and AstraZeneca—now reporting that their COVID-19 shots are 90% or more effective, governments are starting to make decisions about how to distribute the first doses, which will be in limited supply. In the U.S., that initial group will include health care workers, essential workers like law enforcement personnel and first … Read more

Months into the COVID-19 pandemic, with cases and hospitalizations surging across the country, health care workers are getting burned out mentally and physically. Sarah Flanagan, a Florida nurse who routinely treats COVID-19 patients, decided to cut back her hours and to switch to working part-time after feeling disheartened by the spread of false claims online … Read more

Over the past few days, my social media feeds have been jam-packed with pictures and videos of COVID-19 testing lines that stretch multiple blocks. Some people report waiting hours for their turn, while others say they’re being turned away before ever getting the chance. It’s not just here in the New York metro area, either—similar … Read more

(LONDON) — AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease. The results are based on interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca. No hospitalizations or severe cases of … Read more

Other recent studies have also pointed to vaccine hesitancy in communities of color, but Monday’s survey delved deeper into the reasons, polling respondents on a spectrum of questions to get at the roots of their distrust. View original article Contributor: William Wan

Buoyed by promising results from major clinical trials of three coronavirus vaccines, public health officials are preparing for the daunting task ahead of delivering those shots to tens of millions of Americans. View original article Contributor: Lena H. Sun

The drug maker said its vaccine candidate was 70 percent effective on average, and potentially up to 90 percent effective, at preventing Covid-19 in an early analysis. View original article Contributor: